A Multicenter, Cross-sectional Study on the Quality of Life in Long-term Survival Esophageal Cancer Patients After Radical Radiochemotherapy/Radiotherapy

Not yet recruiting

• Conditions: Assessing the Current Quality of Life Status of Esophageal Cancer Patients Who Have Undergone Radical Chemoradiotherapy/Radiotherapy and Long-term Survival

• Registration Number: NCT05828875
• Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Brief Summary

This study is a multicenter cross-sectional survey of esophageal cancer patients who underwent radical chemoradiotherapy/radiotherapy from July 2017 to July 2020 in various medical centers, and who survived without disease progression at the time of the survey. The purpose of this study is to evaluate the current quality of life, as well as the incidence of long-term toxic side effects, nutritional status, and psychological status of esophageal cancer patients cured by radiotherapy.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-04
• Study First Submitted: 2023-04-13
• Study First Submitted QC: 2023-04-24
• Study First Posted: 2023-04-25
• Last Update Submitted: 2023-07-06
• Last Update Posted: 2023-07-07
• Study Start: 2023-08-01
• Primary Completion: 2024-05-01
• Study Completion: 2024-07-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Voluntarily accept this survey and research;
• The age at the time of radiotherapy is between 18-75 years old, and the age at the time of investigation is<80 years old;
• Histologically confirmed esophageal squamous cell carcinoma without undergoing surgical resection;
• Received radical chemoradiotherapy/radiotherapy from July 2017 to July 2020, currently alive and without disease progression;
• Radiotherapy dose ≥ 45Gy.

Exclusion Criteria

• Patients who do not cooperate with this survey;
• Patients who have died at the time of investigation;
• Patients who experience tumor progression within the time frame from the end of radiotherapy to receiving this survey;
• Patients diagnosed with other malignant tumors within the time frame from the end of radiotherapy to receiving this survey;
• Patients with incorrect contact information and missing visits

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of Life Assessment survey	Two years after the end of radiotherapy

Trial Locations

Locations (1)

Tianjin Medical University Cancer Institute & Hospital; 🇨🇳 Tianjin, Tianjin, China